MoneyWorks4Me

Marksans Pharma - Quaterly Results

06 Feb 2026 Evaluate
The revenue zoomed 8.93% to Rs. 3397.29 millions for the quarter ended December 2025 as compared to Rs. 3118.65 millions during the corresponding quarter last year.A humble growth in net profit of 9.82% reported in the quarter ended December 2025 to Rs. 609.12  millions from Rs. 554.63 millions.Operating profit for the quarter ended December 2025 rose to 913.03 millions as compared to 824.48 millions of corresponding quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 3397.29 3118.65 8.93 9799.04 8750.17 11.99 11743.74 8532.73 37.63
Other Income 158.58 307.73 -48.47 760.57 591.52 28.58 698.34 620.73 12.50
PBIDT 913.03 824.48 10.74 2936.31 2154.95 36.26 2738.85 2020.08 35.58
Interest 3.57 3.04 17.43 9.74 8.63 12.86 11.74 9.88 18.83
PBDT 909.46 821.44 10.72 2926.57 2146.32 36.35 2727.11 2010.20 35.66
Depreciation 88.30 74.22 18.97 254.74 212.74 19.74 294.52 291.28 1.11
PBT 821.16 747.22 9.90 2671.83 1933.58 38.18 2432.59 1718.92 41.52
TAX 212.04 192.59 10.10 584.09 426.76 36.87 549.87 381.34 44.19
Deferred Tax 3.65 16.42 -77.77 22.27 20.90 6.56 28.43 6.78 319.32
PAT 609.12 554.63 9.82 2087.74 1506.82 38.55 1882.72 1337.58 40.76
Equity 453.16 453.16 0.00 453.16 453.16 0.00 453.16 453.16 0.00
PBIDTM(%) 26.88 26.44 1.66 29.97 24.63 21.67 23.32 23.67 -1.49
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..